| __timestamp | Perrigo Company plc | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 675200000 | 381287000 |
| Thursday, January 1, 2015 | 771800000 | 452612000 |
| Friday, January 1, 2016 | 1205500000 | 316800000 |
| Sunday, January 1, 2017 | 1146500000 | 330100000 |
| Monday, January 1, 2018 | 1125800000 | 265800000 |
| Tuesday, January 1, 2019 | 1166100000 | 336200000 |
| Wednesday, January 1, 2020 | 1175500000 | 423900000 |
| Friday, January 1, 2021 | 1111400000 | 467000000 |
| Saturday, January 1, 2022 | 1210100000 | 487000000 |
| Sunday, January 1, 2023 | 1274600000 | 477100000 |
Infusing magic into the data realm
In the ever-evolving landscape of the pharmaceutical industry, effective cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of United Therapeutics Corporation and Perrigo Company plc from 2014 to 2023. Over this period, Perrigo consistently outpaced United Therapeutics in SG&A spending, with a notable 89% increase from 2014 to 2023. In contrast, United Therapeutics saw a more modest rise of 25% in the same timeframe. This disparity highlights differing strategic priorities and operational scales. Perrigo's peak in 2023, with expenses reaching approximately 1.27 billion, underscores its expansive market approach. Meanwhile, United Therapeutics' steady growth, culminating in 2023 with expenses around 477 million, reflects a more controlled cost strategy. Understanding these trends offers valuable insights into each company's financial health and strategic direction.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
United Therapeutics Corporation or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: United Therapeutics Corporation vs MiMedx Group, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE
Viatris Inc. and Perrigo Company plc: SG&A Spending Patterns Compared
Corcept Therapeutics Incorporated and Perrigo Company plc: SG&A Spending Patterns Compared
Axsome Therapeutics, Inc. or Perrigo Company plc: Who Manages SG&A Costs Better?
Viking Therapeutics, Inc. and Perrigo Company plc: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.
Perrigo Company plc or Xencor, Inc.: Who Manages SG&A Costs Better?